MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Rehabilitation"

  • 2016 International Congress

    Does distance walked after two minutes predict total 6 minute walk test distance in people with Parkinson’s disease?

    R.P. Duncan, M.E. McNeely, G.M. Earhart (Saint Louis, MO, USA)

    Objective: To determine if the distance walked in the first two minutes of the 6 Minute Walk Test (6MWT) accurately predicts the total distance walked…
  • 2016 International Congress

    Expiratory muscle training for the impaired loudness of speech in Parkinson’s disease: An open-label study

    S. Tomita, T. Oeda, A. Umemura, M. Kohsaka, K. Park, K. Yamamoto, H. Sugiyama, H. Sawada (Kyoto, Japan)

    Objective: To investigate the efficacy of EMT for the impaired loudness of speech in patients with PD, we conducted an open-label pilot trial of EMT.…
  • 2016 International Congress

    Exercise induced analgesia is present in people with Parkinson’s disease

    N.E. Allen, N. Moloney, L.M. Hassett, C.G. Canning, S.J.G. Lewis, K. Cruz-Mavignier, B.K. Barry (Lidcombe, Australia)

    Objective: To investigate if exercise-induced analgesia (EIA) is present in people with Parkinson's disease (PD) compared to an age-matched control group. Background: Pain is a…
  • 2016 International Congress

    A phase 3, placebo-controlled study with an open-label extension: Sustained incobotulinumtoxinA efficacy in upper-limb post-stroke spasticity over 48 weeks

    P. Kanovský, A. Brashear, E.P. Elovic, M.C. Munin, A. Hanschmann, R. Hiersemenzel, C. Marciniak (Olomouc, Czech Republic)

    Objective: To assess the efficacy and safety of incobotulinumtoxinA for upper-limb post-stroke spasticity. Background: Botulinum toxin injections are a recommended therapy for limb spasticity. We…
  • 2016 International Congress

    A comparison of self-report and performance-based balance measures to predict recurrent falls in people with Parkinson’s disease: A cohort study

    L.R.S. Almeida, G.T. Valenca, N.N. Negreiros, E.B. Pinto, J. Oliveira-Filho (Salvador, Brazil)

    Objective: To compare the accuracy of the Activities-specific Balance Confidence Scale (ABC) and Falls Efficacy Scale-International (FES-I) with the Berg Balance Scale (BBS), Dynamic Gait…
  • 2016 International Congress

    Balance training in individual’s with Parkinson’s disease: Therapist-supervised vs. home-based exercise programmes

    E.M. Atterbury, K.E. Welman (Stellenbosch, South Africa)

    Objective: To evaluate and compare the efficacy of a home-based balance programme to therapist-supervised programme on gait parameters, dynamic balance, balance confidence and motivation in…
  • 2016 International Congress

    Changes in handwriting following repetitive transcranial magnetic stimulation over pre-motor cortex in Parkinson’s disease

    A.Y. Son, M.C. Biagioni, E. Pirraglia, A. DiRocco (New York, NY, USA)

    Objective: To observe changes in handwriting following administration of repetitive transcranial magnetic stimulation (rTMS) over pre-motor cortex (pre-MC) in patients with PD. Background: Patients with…
  • 2016 International Congress

    Translation of the European physiotherapy guideline for Parkinson’s disease to Portuguese

    T.T.C. Capato, L.R.S. Almeida, J.M.M. Domingos, B. Bolem, S. Keus (São Paulo, Brazil)

    Objective: To translate and adapt the European Physiotherapy Guideline for Parkinson's disease to Portuguese. Background: In 2014 the European Guideline for Physiotherapy in Parkinson's disease…
  • 2016 International Congress

    Safety and efficacy of escalating doses of incobotulinumtoxinA (400-800U): Increasing improvements in disability due to multifocal upper- and lower-limb spasticity

    J. Wissel, D. Bensmail, B. Rubin, A. Scheschonka, O. Simon, D.M. Simpson (Berlin, Germany)

    Objective: To assess the safety and efficacy of escalating incobotulinumtoxinA doses (400-800U) in patients with spasticity. Background: Botulinum toxin treatment at higher doses than currently…
  • 2016 International Congress

    Predictors of recurrent falls in people with Parkinson’s disease and development of a predictive tool

    L.R.S. Almeida, G.T. Valenca, N.N. Negreiros, E.B. Pinto, J. Oliveira-Filho (Salvador, Brazil)

    Objective: To identify predictors of recurrent falls in people with Parkinson's disease (PD); and to develop a predictive tool for identifying individuals at different categories…
  • « Previous Page
  • 1
  • …
  • 54
  • 55
  • 56
  • 57
  • 58
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley